ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NXTM Nxstage Medical, Inc.

30.00
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Nxstage Medical, Inc. NASDAQ:NXTM NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 30.00 29.99 30.00 0 01:00:00

NxStage to Present at Canaccord Genuity 36th Annual Growth Conference

02/08/2016 1:00pm

PR Newswire (US)


Nxstage Medical (NASDAQ:NXTM)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Nxstage Medical Charts.

LAWRENCE, Mass., Aug. 2, 2016 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that Jeffrey H. Burbank, Chief Executive Officer, and Matthew Towse, Chief Financial Officer, will present at the Canaccord Genuity 36th Annual Growth Conference on Wednesday, August 10th at 8:30 a.m. ET in Boston, MA.

NxStage Medical, Inc. (PRNewsFoto/NxStage Medical, Inc.)

A webcast of the presentation will be made available through the Investor Relations section of the Company's website at http://ir.nxstage.com/.

About NxStage
NxStage Medical, Inc. (Nasdaq: NXTM) is a leading medical technology company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease (ESRD) and acute kidney failure. NxStage has also established a small number of dialysis clinics committed to the development of innovative care delivery models for patients with ESRD. For more information on NxStage and its products and services, please visit the Company's website at http://www.nxstage.com and www.nxstagekidneycare.com. 

Forward-Looking Statements
This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Examples of these forward-looking statements include statements as to Messrs. Burbank and Towse's plans to present at these conferences. NxStage specifically disclaims any obligation to update these forward-looking statements. These forward-looking statements should not be relied upon as representing NxStage's expectations or beliefs as of any date subsequent to the date of this press release.

Contact:
Kristen K. Sheppard, Esq.
Investor Relations
ksheppard@nxstage.com

Logo - http://photos.prnewswire.com/prnh/20110503/MM94799LOGO 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nxstage-to-present-at-canaccord-genuity-36th-annual-growth-conference-300307260.html

SOURCE NxStage Medical, Inc.

Copyright 2016 PR Newswire

1 Year Nxstage Medical Chart

1 Year Nxstage Medical Chart

1 Month Nxstage Medical Chart

1 Month Nxstage Medical Chart

Your Recent History

Delayed Upgrade Clock